Repligen Corp (NAS:RGEN)
$ 138.4 +12.01 (+9.5%) Market Cap: 7.81 Bil Enterprise Value: 7.71 Bil PE Ratio: 153.78 PB Ratio: 3.71 GF Score: 83/100

Repligen Corp at Evercore ISI Healthcare Conference Transcript

Dec 03, 2025 / 06:20PM GMT
Release Date Price: $166.52 (+0.91%)
Daniel Markowitz
Evercore Inc - Analyst

We're live? Great. Awesome. Thank you, everyone, for joining. For those of you who don't know me, I'm Daniel Markowitz. I cover the life science tools and diagnostics at medtech space here at Evercore ISI. Today we're joined by Repligen. We have with us CFO, Jason Garland; and from Investor Relations, Steven Chehames. So thank you both for joining.

Steven Chehames
Repligen Corp - Director - Investor Relations

Thanks for having us.

Jason Garland
Repligen Corp - Chief Financial Officer

Hi, everyone.

Questions & Answers

Daniel Markowitz;Jason Garland
Evercore Inc - Analyst;Repligen

Awesome. So lots to get into here. I would love to just start off on 3Q performance. So I think you guys delivered 18% organic growth, double-digit growth across every franchise. Can you just talk about some of the drivers of this performance? Were there any standout products or customer categories to call out?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot